bevacizumab
roche
['#gi', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
#asco22 #asco2022 #gioncology crc oral abstract #5 gercor-prodige rct ph iii france/ireland/israel arm 1: folfiri/cetux--&gt;folfox/bev (both continuous) arm 2: optimox/bev (stop and go)--&gt;folfiri/bev (continuous)--&gt;anti-egfr
Stanford Oncologist || BYU alum || Penn Med alum || author || American Studies amateur || religious studies amateur || podcasting @ https://t.co/KnVbI8oZ43